IIT Guwuhati is working with Ahmedabad-based Hester Biosciences to develop a coronavirus vaccine. The vaccine will be based on recombinant avian paramyxovirus-based vector platform and should be ready for animal trials by the end of this year, IIT-G said in a statement. The development is still in its early stages and Hester’s involvement would be from master seed development up to release of the commercial vaccine.